Overview
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
Description
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
Eligibility
Inclusion Criteria:
- Patients \>= 18 years old;
- Diagnosed with Merkel cell carcinoma of skin, ongoing for local treatment, systemic treatment, complementary treatment or an active follow-up;
- Informed for the study and no-opposed for participation;
- Affiliated with a social security scheme or in an equivalent situation.
Exclusion Criteria:
- Patients ongoing another interventional clinical trial;
- Patients under guardianship or trusteeship;
- Pregnancy or breastfeed;
- Patients refusal.
